Výsledky vyhľadávania - "Glioblastoma therapy"

Single-atom Ca nanozyme induces glioma death through Ca2+-overload-enhanced catalytic tumor nanotherapy, ferroptosis and synergistic remodeling of the immune microenvironment

Autori: Zhizhong Jin Xinqiao Li Xiaoyu Hou a ďalší

Zdroj: Journal of Nanobiotechnology, Vol 23, Iss 1, Pp 1-19 (2025)

Predmety: Single-atom nanozyme, Glioblastoma therapy, Ferroptosis, Pyroptosis, Immune reprogramming, Biotechnology, TP248.13-248.65, Medical technology, R855-855.5

Popis súboru: electronic resource

Relation: https://doaj.org/toc/1477-3155

Prístupová URL adresa: https://doaj.org/article/607fb6610aba44918f9a21a259582c59

Biomimetic Cu2−xSe nanoplatforms for efficient glioblastoma treatment: overcoming the blood-brain barrier and boosting Immunogenetic cell death

Autori: Sijia Lin Haiyan Xing Yu Zeng a ďalší

Zdroj: Journal of Nanobiotechnology, Vol 23, Iss 1, Pp 1-16 (2025)

Predmety: Glioblastoma therapy, Blood-brain barrier penetration, Immunogenetic cell death, Oxidative damage, Biotechnology, TP248.13-248.65, Medical technology, R855-855.5

Popis súboru: electronic resource

Relation: https://doaj.org/toc/1477-3155

Prístupová URL adresa: https://doaj.org/article/2e642b816c664a5d8efb43f97c0280d7

Multimodal treatment of glioblastoma with multiple lesions - a multi-center retrospective analysis

Autori: Harald Krenzlin Dragan Jankovic Alice Dauth a ďalší

Prispievatelia: Harald Krenzlin Dragan Jankovic Alice Dauth a ďalší

Zdroj: J Neurooncol

Predmety: Male, Adult, Brain Neoplasms, Research, 610 Medizin, Female [MeSH], Follow-Up Studies [MeSH], Aged [MeSH], Adult [MeSH], Humans [MeSH], Multimodal therapy, Retrospective Studies [MeSH], Middle Aged [MeSH], Glioblastoma/pathology [MeSH], Glioblastoma, Glioblastoma/therapy [MeSH], Neurosurgical Procedures [MeSH], Extent of resection, Survival Rate [MeSH], Multicentric, Glioblastoma/mortality [MeSH], Male [MeSH], Prognosis [MeSH], Brain Neoplasms/mortality [MeSH], Multifocal, Combined Modality Therapy [MeSH], Brain Neoplasms/pathology [MeSH], Brain Neoplasms/therapy [MeSH], Middle Aged, Prognosis, Combined Modality Therapy, Neurosurgical Procedures, ddc, Survival Rate, 03 medical and health sciences, 0302 clinical medicine, 610 Medical sciences, Humans, Female, Retrospective Studies, Aged, Follow-Up Studies

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39560695
https://repository.publisso.de/resource/frl:6501576
https://mediatum.ub.tum.de/doc/1770657/document.pdf

Distinguishing glioblastoma progression from treatment-related changes using DTI directionality growth analysis

Autori: R. van den Elshout B. Ariëns M. Esmaeili a ďalší

Zdroj: Neuroradiology
Neuroradiology, 66, 12, pp. 2143-2151

Predmety: Male, Adult, Brain Neoplasms, glioblastoma, VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750, Contrast Media, Middle Aged, Female [MeSH], Disease Progression [MeSH], Aged [MeSH], Adult [MeSH], Humans [MeSH], Diffusion Tensor Imaging/methods [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], DTI, MRI, Glioblastoma/pathology [MeSH], Satellitosis, Contrast Media [MeSH], Glioblastoma, Glioblastoma/therapy [MeSH], Diagnosis, Differential [MeSH], Male [MeSH], Image Interpretation, Computer-Assisted/methods [MeSH], Lesion development, Brain Neoplasms/diagnostic imaging [MeSH], Glioblastoma/diagnostic imaging [MeSH], Diagnostic Neuroradiology, Brain Neoplasms/pathology [MeSH], Diagnosis, Differential, 03 medical and health sciences, Diffusion Tensor Imaging, 0302 clinical medicine, Medical Imaging - Radboud University Medical Center, Image Interpretation, Computer-Assisted, Disease Progression, Humans, Female, Aged, Retrospective Studies

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39153088
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/313328
https://repository.ubn.ru.nl//bitstream/handle/2066/313328/313328.pdf
https://hdl.handle.net/2066/313328
https://hdl.handle.net/11250/3170975
https://repository.publisso.de/resource/frl:6522474

Disrupting glioblastoma networks with tumor treating fields (TTFields) in in vitro models

Autori: Schlieper-Scherf, Steffen Hebach, Nils Hausmann, David a ďalší

Zdroj: J Neurooncol

Predmety: 0301 basic medicine, 0303 health sciences, Brain Neoplasms, Research, Electric Stimulation Therapy, Organoids, 03 medical and health sciences, Cell Line, Tumor, Tumor Cells, Cultured, Humans, Calcium, Glioma, Calcium/metabolism [MeSH], Cell Line, Tumor [MeSH], Cell Proliferation [MeSH], Organoids [MeSH], Humans [MeSH], Cancer cell network, Electric Stimulation Therapy/methods [MeSH], Glioblastoma/metabolism [MeSH], Glioblastoma/pathology [MeSH], Glioblastoma/therapy [MeSH], TTFields, Tumor Cells, Cultured [MeSH], Tumor microtubes, Cancer neuroscience, Brain Neoplasms/pathology [MeSH], Brain Neoplasms/therapy [MeSH], Glioblastoma, Cell Proliferation

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39088157
https://repository.publisso.de/resource/frl:6512352

Effects of tumor treating fields (TTFields) on human mesenchymal stromal cells

Autori: Strack, Maren Kueckelhaus, Jan Diebold, Martin a ďalší

Zdroj: J Neurooncol

Predmety: 0301 basic medicine, Brain Neoplasms, Research, Mesenchymal Stem Cells, Apoptosis, Cell Differentiation, Electric Stimulation Therapy, 03 medical and health sciences, 0302 clinical medicine, Cell Movement, Tumor Microenvironment, Humans, Glioma, Cell Proliferation [MeSH], Mesenchymal stromal cells, Humans [MeSH], Cell Movement [MeSH], Electric Stimulation Therapy/methods [MeSH], Cell Differentiation [MeSH], Apoptosis [MeSH], Glioblastoma/pathology [MeSH], Tumor microenvironment, Glioblastoma/therapy [MeSH], Mesenchymal stem cells, Brain Neoplasms/pathology [MeSH], Brain Neoplasms/therapy [MeSH], Mesenchymal Stem Cells/physiology [MeSH], Tumor Microenvironment [MeSH], Glioblastoma, Cell Proliferation

Popis súboru: pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38900237
https://repository.publisso.de/resource/frl:6499659

Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model

Autori: Conrad, Katharina Löber-Handwerker, Ronja Hazaymeh, Mohammad a ďalší

Prispievatelia: Conrad, Katharina Löber-Handwerker, Ronja Hazaymeh, Mohammad a ďalší

Zdroj: J Neurooncol

Predmety: Male, Adult, Aged, 80 and over, Survival analysis, Aged, 80 and over [MeSH], Aged [MeSH], Risk Assessment [MeSH], Prognostic factors, Decision Trees [MeSH], Male [MeSH], Brain Neoplasms/mortality [MeSH], Brain Neoplasms/diagnosis [MeSH], Algorithms [MeSH], Glioblastoma/diagnosis [MeSH], Female [MeSH], Follow-Up Studies [MeSH], Adult [MeSH], Humans [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Glioblastoma, Glioblastoma/therapy [MeSH], Survival Rate [MeSH], Glioblastoma/mortality [MeSH], Research, Prognosis [MeSH], Precision Medicine [MeSH], Brain Neoplasms/therapy [MeSH], Brain Neoplasms, Decision Trees, Middle Aged, Prognosis, Risk Assessment, 3. Good health, Survival Rate, 03 medical and health sciences, 0302 clinical medicine, Humans, Female, Precision Medicine, Algorithms, Aged, Retrospective Studies, Follow-Up Studies

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38639854
https://resolver.sub.uni-goettingen.de/purl?gro-2/143037
https://repository.publisso.de/resource/frl:6495537

RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma

Autori: Haidy A. Saleh Nicola Mitwasi Liliana R. Loureiro a ďalší

Zdroj: Cancer Gene Ther

Predmety: 0301 basic medicine, Receptors, Chimeric Antigen, Brain Neoplasms, T-Lymphocytes, Cell Line, Tumor [MeSH], Antibodies, Bispecific/immunology [MeSH], Glioblastoma/immunology [MeSH], T-Lymphocytes/metabolism [MeSH], Receptors, Chimeric Antigen/immunology [MeSH], 13, 42, 692/699/67/580, Glioblastoma/metabolism [MeSH], TWEAK Receptor/metabolism [MeSH], Glioblastoma/pathology [MeSH], 59/5, Receptors, Chimeric Antigen/genetics [MeSH], Xenograft Model Antitumor Assays [MeSH], Killer Cells, Natural/immunology [MeSH], Glioblastoma/genetics [MeSH], 13/1, Killer Cells, Natural/metabolism [MeSH], Brain Neoplasms/genetics [MeSH], T-Lymphocytes/immunology [MeSH], Brain Neoplasms/immunology [MeSH], Humans [MeSH], 101/1, 101, Animals [MeSH], Glioblastoma/therapy [MeSH], TWEAK Receptor/genetics [MeSH], Antibodies, Bispecific/pharmacology [MeSH], Mice [MeSH], Article, 82, 82/1, 59, 692/308/153, Immunotherapy, Adoptive/methods [MeSH], Receptors, Chimeric Antigen/metabolism [MeSH], 14, Brain Neoplasms/metabolism [MeSH], article, Brain Neoplasms/pathology [MeSH], Brain Neoplasms/therapy [MeSH], Xenograft Model Antitumor Assays, Immunotherapy, Adoptive, Killer Cells, Natural, Mice, 03 medical and health sciences, 0302 clinical medicine, TWEAK Receptor, Cell Line, Tumor, Antibodies, Bispecific, Humans, Animals, Glioblastoma

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38582787
https://repository.publisso.de/resource/frl:6497262

Treatment of Brain Cancer (Glioblastoma) Using the ψ–Hamzah Model.

Autori: JALALI, SEYED RASOUL

Predmety: ψ–Hamzah glioblastoma therapy, fractional calculus in brain cancer, fractal tumor growth modeling, complex integral cancer dynamics, nonlinear glioblastoma treatment, quantum fractal oncology model, ψ neuro-oncology therapeutic system, glioblastoma multiforme ψ model therapy, drug resistance fractal modeling in GBM, blood–brain barrier nanoparticle delivery ψ model, nanoparticle glioblastoma vaccine ψ therapy, fractal drug diffusion brain tumors, fractional-order glioblastoma dynamics, chaotic immune regulation ψ cancer, ψ glioblastoma nanodrug design, glioblastoma-specific antigen fractal vaccine, tumor heterogeneity ψ fractal simulation, nanoparticle penetration glioblastoma ψ model, Caputo fractional brain tumor modeling, fractal pharmacokinetics glioblastoma drugs, MRI fractal biomarkers glioblastoma ψ, PET fractal tumor imaging ψ oncology, ψ glioblastoma immunotherapy design, fractal immune recalibration brain tumors, chaos-driven glioblastoma suppression ψ model, ψ vaccine adjuvant glioblastoma therapy, dendrimer nanoparticle brain cancer vaccine, glioblastoma peptide fractal vaccine ψ, tumor angiogenesis inhibition ψ fractal nanodrug, glioblastoma proliferation chaos modeling ψ

Relation: https://zenodo.org/records/16907507; oai:zenodo.org:16907507; https://doi.org/10.5281/zenodo.16907507

Dostupnosť: https://doi.org/10.5281/zenodo.16907507
https://zenodo.org/records/16907507

Sarcopenia is associated with chemoradiotherapy discontinuation and reduced progression-free survival in glioblastoma patients

Autori: Fabian M. Troschel Benjamin O. Troschel Maren Kloss a ďalší

Zdroj: Strahlenther Onkol

Predmety: Male, Sarcopenia, Brain Neoplasms, Radiotherapy Planning, Computer-Assisted, Chemoradiotherapy, Middle Aged, Progression-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Sarcopenia/etiology [MeSH], Disease Progression [MeSH], Aged [MeSH], Progression-Free Survival [MeSH], Radiation therapy, Palliative care, Original Article, Tomography, X-Ray Computed [MeSH], Glioblastoma/radiotherapy [MeSH], Male [MeSH], Radiation Dose Hypofractionation [MeSH], Frailty, Brain Neoplasms/mortality [MeSH], Withholding Treatment [MeSH], Female [MeSH], Brain Neoplasms/radiotherapy [MeSH], Computed tomography, Radiotherapy Planning, Computer-Assisted [MeSH], Humans [MeSH], Prognostic biomarker, Retrospective Studies [MeSH], Middle Aged [MeSH], Glioblastoma/therapy [MeSH], Glioblastoma/mortality [MeSH], Body composition, Chemoradiotherapy [MeSH], Brain Neoplasms/therapy [MeSH], Withholding Treatment, Disease Progression, Humans, Female, Radiation Dose Hypofractionation, Glioblastoma, Tomography, X-Ray Computed, Aged, Retrospective Studies

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38546749
https://repository.publisso.de/resource/frl:6508739

Implantable devices for resected glioblastoma therapy

Autori: Xiaoyu Chang Hui Guo Yunqian Li a ďalší

Zdroj: Asian Journal of Pharmaceutical Sciences, Vol 20, Iss 2, Pp 101034- (2025)

Predmety: Biomaterial, Implantable device, Inhibition of recurrence, Prolongation of survival, Resected glioblastoma therapy, Therapeutics. Pharmacology, RM1-950

Popis súboru: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S1818087625000200; https://doaj.org/toc/1818-0876

Prístupová URL adresa: https://doaj.org/article/0dbe6067c08045eba840a55796bbc745

Fast Evolving Glioblastoma in a Pregnant Woman: Diagnostic and Therapeutic Challenges

Autori: Ivan Bogdanovic Rosanda Ilic Aleksandar Kostic a ďalší

Zdroj: Diagnostics, Vol 15, Iss 15, p 1836 (2025)

Predmety: pregnancy, brain cancer, magnetic resonance spectroscopy, glioblastoma therapy, maternal–fetal outcome, Medicine (General), R5-920

Popis súboru: electronic resource

Relation: https://www.mdpi.com/2075-4418/15/15/1836; https://doaj.org/toc/2075-4418

Prístupová URL adresa: https://doaj.org/article/27b4874f27264d44b2427c9b7cfeeed9

NIR-II Engineered Exosome Nanotheranostic Probes for “Oriented Blasting” in Orthotopic Glioblastoma

Autori: Donghu Yu Qihang Ding Chunbai Xiang a ďalší

Predmety: Biochemistry, Molecular Biology, Pharmacology, Biotechnology, Immunology, Cancer, Space Science, Biological Sciences not elsewhere classified, Information Systems not elsewhere classified, upon laser irradiation, theranostics platform aimed, synergistic therapeutic effects, photodynamic therapeutic capabilities, modulate antitumor immunity, innovative therapeutic strategies, improving clinical outcomes, combines robust fluorescence, >, studies demonstrate, lethal brain tumor, effective treatment options, orthotopic glioblastoma glioblastoma, immune response pathways, immune response, glioblastoma therapy, tumor targeting, effective approach, vivo <, urgent need, targeted delivery

Dostupnosť: https://doi.org/10.1021/acsnano.5c01541.s001
https://figshare.com/articles/journal_contribution/NIR-II_Engineered_Exosome_Nanotheranostic_Probes_for_Oriented_Blasting_in_Orthotopic_Glioblastoma/29371490

Prospective Molecular Targets for Natural Killer Cell Immunotherapy against Glioblastoma Multiforme

Autori: Cooksey, Luke C. Friesen, Derek C. Mangan, Enrique D. a ďalší

Zdroj: Cells

Predmety: glioblastoma, immune checkpoints, immunotherapy, natural killer (NK) cells, Glioblastoma / therapy, Glioblastoma / immunology, Killer Cells, Natural / immunology, Immunotherapy / methods

Popis súboru: application/pdf

Relation: https://doi.org/10.3390/cells13181567; Cooksey, L. C., Friesen, D. C., Mangan, E. D., & Mathew, P. A. (2024). Prospective Molecular Targets for Natural Killer Cell Immunotherapy against Glioblastoma Multiforme. Cells, 13(18), 1567. https://doi.org/10.3390/cells13181567; https://hdl.handle.net/20.500.12503/33042; 13; 18

Dostupnosť: https://hdl.handle.net/20.500.12503/33042

Potential of Curcumin and Its Analogs in Glioblastoma Therapy

Autori: Agnieszka Nowacka Ewa Ziółkowska Wojciech Smuczyński a ďalší

Zdroj: Antioxidants ; Volume 14 ; Issue 3 ; Pages: 351

Predmety: curcumin, glioblastoma, GBM, anti-cancer, glioblastoma therapy, oxidative stress, Pl3K/Akt, NF-κB, JAK/STAT, p53, MAPK, Shh, radiosensitization, curcumin nanoformulations

Geografické téma: agris

Popis súboru: application/pdf

Relation: https://dx.doi.org/10.3390/antiox14030351

Dostupnosť: https://doi.org/10.3390/antiox14030351

The impact of short-course hypofractionated radiotherapy on multimodality treatment utilisation, compliance, and outcome in glioblastoma patients: a Danish patterns of care study: a Danish patterns of care study

Autori: Vishnuga Sivarasah Vamsi Slavka Lukacova Rikke Hedegaard Dahlrot a ďalší

Zdroj: Vamsi, V S, Lukacova, S, Dahlrot, R H, Guldberg, T L, Korshøj, A R, Muhic, A & Trip, A K 2023, 'The impact of short-course hypofractionated radiotherapy on multimodality treatment utilisation, compliance, and outcome in glioblastoma patients: a Danish patterns of care study', Acta Oncologica, vol. 62, no. 11, pp. 1511-1519. https://doi.org/10.1080/0284186X.2023.2238884
Vamsi, V S, Lukacova, S, Dahlrot, R H, Guldberg, T L, Korshøj, A R, Muhic, A & Trip, A K 2023, 'The impact of short-course hypofractionated radiotherapy on multimodality treatment utilisation, compliance, and outcome in glioblastoma patients : a Danish patterns of care study', Acta Oncologica, vol. 62, no. 11, pp. 1511-1519. https://doi.org/10.1080/0284186X.2023.2238884

Predmety: Adult, Radiation, Denmark, hypofractionated radiotherapy, long-course radiotherapy, survival, 3. Good health, Treatment Outcome, Glioblastoma/therapy, short-course radiotherapy, conventionally fractionated radiotherapy, Humans, Radiation Dose Hypofractionation, patterns of care, Dose Fractionation, Radiation, Glioblastoma, Dose Fractionation, Retrospective Studies

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/37558643
https://pure.au.dk/portal/en/publications/920cd757-0fc1-48cc-935d-7c1f4c9556ea
https://doi.org/10.1080/0284186X.2023.2238884

The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy

Autori: Mattei, Vincenzo Santilli, Francesca Martellucci, Stefano a ďalší

Zdroj: International Journal of Molecular Sciences. 22(8)

Predmety: Biochemistry and Cell Biology, Biological Sciences, Medicinal and Biomolecular Chemistry, Chemical Sciences, Microbiology, Brain Cancer, Brain Disorders, Neurosciences, Orphan Drug, Stem Cell Research, Cancer, Stem Cell Research - Nonembryonic - Human, Rare Diseases, Animals, Antineoplastic Agents, Biomarkers, Brain Neoplasms, Cell Differentiation, Cell Self Renewal, Disease Susceptibility, Drug Resistance, Neoplasm, Glioblastoma, Humans, Neoplastic Stem Cells, Signal Transduction, glioblastoma, glioblastoma stem cells, cancer stem cells, glioblastoma therapy resistance, glioblastoma stem cells and therapy resistance, new drugs in the treatment of glioblastoma stem cells, Other Chemical Sciences, Genetics, Other Biological Sciences, Chemical Physics, Biochemistry and cell biology, Medicinal and biomolecular chemistry

Popis súboru: application/pdf

Prístupová URL adresa: https://escholarship.org/uc/item/7383s4cb
https://escholarship.org/content/qt7383s4cb/qt7383s4cb.pdf

Nanomedicine for glioblastoma: Progress and future prospects

Autori: Cho, Jae Yong Imran, Mohammad Azhar Khan, Mohd Imran a ďalší

Prispievatelia: Cho, Jae Yong Imran, Mohammad Azhar Khan, Mohd Imran a ďalší

Zdroj: Seminars in Cancer Biology. 86:172-186

Predmety: Progress and Future Prospects.-, Seminars in cancer biology, 2022 [Khan I., Baig M. H. , Mahfooz S., Imran M. A. , Khan M. I. , Dong J., Cho J. Y. , Hatiboglu M. A. , -Nanomedicine for Glioblastoma], 0301 basic medicine, 0303 health sciences, Brain Neoplasms* / diagnosis, Temozolomide / therapeutic use, Brain Neoplasms, Brain Neoplasms* / drug therapy, Glioblastoma* / therapy, Glioblastoma* / drug therapy, Exosomes, Blood-Brain Barrier / pathology, 3. Good health, 03 medical and health sciences, Nanoparticle, Nanomedicine, Blood brain barrier, Blood-Brain Barrier, Liposomes, Temozolomide, Humans, Glioblastoma

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/35760272
http://hdl.handle.net/20.500.12645/30788

Lipid‐Polymer Nanoparticles Mediate Compartmentalized Delivery of Cas9 and sgRNA for Glioblastoma Vasculature and Immune Reprogramming

Autori: Huaqing Zhang Wenxin Jiang Tingting Song a ďalší

Zdroj: Advanced Science, Vol 11, Iss 32, Pp n/a-n/a (2024)

Predmety: Cas9 and sgRNA, compartmentalized delivery, glioblastoma therapy, lipid‐polymer nanoparticles, STAT3 gene editing, Science

Popis súboru: electronic resource

Relation: https://doaj.org/toc/2198-3844

Prístupová URL adresa: https://doaj.org/article/5acebf9b95114d6aa4577eb130f35170

Lomustine with or without reirradiation for first progression of glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III study: study protocol for a randomized phase III study

Autori: Preusser, Matthias Kazda, Tomáš Le Rhun, Emilie a ďalší

Prispievatelia: Preusser, Matthias Kazda, Tomáš Le Rhun, Emilie a ďalší

Zdroj: Trials
Trials, Vol 25, Iss 1, Pp 1-10 (2024)

Predmety: Medicine (General), Time Factors, 610 Medicine & health, Study Protocol, R5-920, Disease Progression [MeSH], Randomized controlled trial, Progression-Free Survival [MeSH], Antineoplastic Agents, Alkylating/therapeutic use [MeSH], Glioblastoma/pathology [MeSH], Reirradiation, Clinical Trials, Phase III as Topic [MeSH], Glioblastoma/drug therapy [MeSH], Randomized Controlled Trials as Topic [MeSH], Glioblastoma/radiotherapy [MeSH], Quality of Life [MeSH], Lomustine/adverse effects [MeSH], Brain Neoplasms/mortality [MeSH], Lomustine/administration, Lomustine, Brain Neoplasms/radiotherapy [MeSH], Humans [MeSH], Pragmatic Clinical Trials as Topic [MeSH], Chemoradiotherapy/methods [MeSH], Progression, Multicenter Studies as Topic [MeSH], Glioblastoma, Glioblastoma/therapy [MeSH], LEGATO, Time Factors [MeSH], Lomustine/therapeutic use [MeSH], Glioblastoma/mortality [MeSH], Brain Neoplasms/pathology [MeSH], Brain Neoplasms/therapy [MeSH], Pragmatic Clinical Trials as Topic, Humans, Multicenter Studies as Topic, Antineoplastic Agents, Alkylating, Randomized Controlled Trials as Topic, Brain Neoplasms, Chemoradiotherapy, Progression-Free Survival, 10040 Clinic for Neurology, 3. Good health, Clinical Trials, Phase III as Topic, 10032 Clinic for Oncology and Hematology, Disease Progression, Quality of Life

Popis súboru: application/pdf; s13063_024_08213_7.pdf - application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38849943
https://doaj.org/article/da487c7b1214453fb930ea4fb6b04a3a
https://hdl.handle.net/1887/4209080
https://repository.publisso.de/resource/frl:6505004
https://www.zora.uzh.ch/id/eprint/260249/
https://doi.org/10.5167/uzh-260249